BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21329460)

  • 1. IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma.
    Giannitrapani L; Soresi M; Giacalone A; Campagna ME; Marasà M; Cervello M; Marasà S; Montalto G
    OMICS; 2011 Mar; 15(3):183-6. PubMed ID: 21329460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease.
    Falleti E; Fabris C; Toniutto P; Fontanini E; Cussigh A; Bitetto D; Fumolo E; Fornasiere E; Bragagnini W; Pinato DJ; Minisini R; Pirisi M
    Oncology; 2009; 77(5):304-13. PubMed ID: 19940521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum PAI-1 and PAI-1 4G/5G Polymorphism in Hepatitis C Virus-Induced Cirrhosis and Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients.
    El Edel RH; Essa ES; Essa AS; Hegazy SA; El Rowedy DI
    Viral Immunol; 2016 Nov; 29(9):510-515. PubMed ID: 27459171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vascular endothelial growth factor -634 G/C and its soluble receptor on chronic liver disease and hepatocellular carcinoma.
    Ratnasari N; Nurdjanah S; Sadewa AH; Hakimi M
    Arab J Gastroenterol; 2016 Jun; 17(2):61-6. PubMed ID: 27426958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
    Tanabe KK; Lemoine A; Finkelstein DM; Kawasaki H; Fujii T; Chung RT; Lauwers GY; Kulu Y; Muzikansky A; Kuruppu D; Lanuti M; Goodwin JM; Azoulay D; Fuchs BC
    JAMA; 2008 Jan; 299(1):53-60. PubMed ID: 18167406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
    Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
    Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
    Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-fetoprotein gene polymorphisms and risk of HCC and cirrhosis.
    Suriapranata IM; Sudania WM; Tjong WY; Suciptan AA; Gani RA; Hasan I; Sanityoso A; Budihusodo U; Miskad UA; Akil F; Lelosutan SA; Martamala R; Yusuf I; Lesmana LA; Sulaiman A; Tai S
    Clin Chim Acta; 2010 Mar; 411(5-6):351-8. PubMed ID: 19968979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6(-572/-597) polymorphism and expression in HBV disease chronicity in an Indian population.
    Saxena R; Chawla YK; Verma I; Kaur J
    Am J Hum Biol; 2014; 26(4):549-55. PubMed ID: 24841049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-α, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma.
    Giacalone A; Montalto G; Giannitrapani L; Balasus D; Terranova A; Cervello M; Soresi M; Marasà L
    OMICS; 2011 Mar; 15(3):193-6. PubMed ID: 21319995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma.
    Chen TY; Li YC; Liu YF; Tsai CM; Hsieh YH; Lin CW; Yang SF; Weng CJ
    Ann Surg Oncol; 2011 Aug; 18(8):2348-56. PubMed ID: 21298348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
    Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
    Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the relationship between single-nucleotide polymorphisms in IL-6, IL-10 genes and HBV-related hepatocellular carcinoma].
    Qiu XQ; Bei CH; Yu HP; Zeng XY; Zhong QA
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 May; 32(5):510-3. PubMed ID: 21569738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men].
    Liu S; Qiu XQ; Zeng XY; Bai H; Bei CH; Yang Y
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.